After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/5s9rDvyFX74″ height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/5s9rDvyFX74/150724082622.htm
For prostate cancer patients, risk-specific therapies now more the norm
24 julio 2015
Volver